ResMed Inc (STU:RME)
€ 232.3 -1.9 (-0.81%) Market Cap: 34.52 Bil Enterprise Value: 34.92 Bil PE Ratio: 32.70 PB Ratio: 6.98 GF Score: 98/100

Resmed Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 14, 2022 / 08:20PM GMT
Release Date Price: €199.98 (+2.03%)
Chris Cooper
Goldman Sachs Group, Inc., Research Division - Research Analyst

Okay. Good afternoon, everyone. For the next session, we are fortunate to be joined by Mick Farrell, the CEO of ResMed. Most of you will know they are a leading player in sleep and respiratory health globally. Thanks for joining us, Mick.

Michael J. Farrell
ResMed Inc. - CEO & Director

Happy to be here. Thanks for having me.

Questions & Answers

Chris Cooper
Goldman Sachs Group, Inc., Research Division - Research Analyst

Let's get straight into it. So overnight, you announced a $1 billion acquisition. Unfortunately, many of us here would have missed the call that you hosted this morning. Perhaps you could just run us through the final points and contextualize the German business for us and walk us through the value proposition.

Michael J. Farrell
ResMed Inc. - CEO & Director

Yes, absolutely. And we didn't intend M&A goes at the speed it goes. We didn't intend to -- for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot